IRIS Company Secretarial true 2023-04-01 2024-03-31 2022-04-01 2023-03-31 false 10043421 uk-bus:Director1 2023-04-01 2024-03-31 10043421 2023-04-01 2024-03-31 10043421 2023-04-01 2024-03-31 10043421 2024-03-31 10043421 2023-03-31 10043421 uk-bus:EntityHasNeverTraded 2023-04-01 2024-03-31 10043421 uk-bus:FRS102 2023-04-01 2024-03-31 10043421 uk-bus:FullAccounts 2023-04-01 2024-03-31 10043421 uk-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 100434212023-03-31 10043421 uk-bus:OrdinaryShareClass1 2023-04-01 2024-03-31 iso4217:GBP xbrli:shares

Registered Number 10043421

Exochrome Biosciences Limited

Dormant Accounts

31 March 2024

Exochrome Biosciences Limited Registered Number 10043421

Balance Sheet as at 31 March 2024

2024 2023
£ £
Called up share capital not paid
1.00
1.00

Net assets
1.00
1.00


Issued share capital
100 A Ordinary shares of £0.01 each 1.00 1.00
Total shareholders' funds
1.00
1.00

STATEMENTS

  1. For the year ending 31 March 2024 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 05 November 2024

And signed on their behalf by:
Dr Nicholas James Master, Director